メラニン濃縮ホルモン受容体の分子特性
Y Saito1, H P Nothacker, Z Wang
1Department of Pharmacology, University of California, Irvine 92697-4625, USA.
Nature
|July 27, 1999
まとめ
研究者は,孤児のGタンパク質結合受容体 (GPCR) の天然リガンドであるSLC-1をメラニン濃縮ホルモン (MCH) として特定しました. この神経ペプチドは,食事の行動を調節し,SLC-1経路を活性化し,食品消費の調節のための治療的可能性を示唆しています.
科学分野:
- 神経科学は神経科学である.
- 分子生物学は分子生物学である.
- 薬理学 薬理学とは
背景:
- 孤児Gタンパク質結合受容体 (GPCRs) は,新しいシグナル伝達分子を発見するための標的である.
- GPCRは構造的に似ているが,未知のリガンドを結合する.
- 孤児GPCRのリガンドを特定することは,細胞のコミュニケーションを理解するために不可欠です.
研究 の 目的:
- 孤児GPCR,SLC-1の天然リガンドを分離し,特徴づけること.
- 特定されたリガンド受容体相互作用の機能的役割を調査する.
- この受容体系を標的とした治療の潜在的応用を探求する.
主な方法:
- 脳抽出物からSLC-1リガンドを分離した.
- ニューロペプチドのメラニン濃縮ホルモン (MCH) をリガンドとして特徴づける.
- G ((alpha) iおよびG ((alpha) qタンパク質を用いた活性化アッセイ.
- 脳内のMCH受容体の組織局所化研究.
主要な成果:
- メラニン濃縮ホルモン (MCH) は,孤児GPCR,SLC-1.の天然リガンドとして特定されました.
- MCHは,G ((alpha) i/G ((alpha) qタンパク質を介してナノモラー濃度でSLC-1経路を活性化します.
- MCH受容体は,嗅覚学習と補強に関連する脳領域で発現する.
結論:
- MCH-SLC-1システムは,哺乳類の脳機能,特に餌食行動の調節に役割を果たしています.
- 特定された受容体の局所化は,嗅覚学習と報酬メカニズムにおける役割を示唆しています.
- MCH受容体へのターゲティングは,食物消費のニューロン制御を調節するための治療戦略を提供することができる.
関連する概念動画
Protein and Protein Structure
Proteins are one of the most abundant organic molecules in living systems and have the most diverse range of functions of all macromolecules. Proteins may be structural, regulatory, contractile, or protective. They may serve in transport, storage, or membranes; or they may be toxins or enzymes. Their structures, like their functions, vary greatly. They are all, however, amino acid polymers arranged in a linear sequence.
A protein's shape is critical to its function. For example, an enzyme can...
A protein's shape is critical to its function. For example, an enzyme can...
Spare Receptors
Some receptors remain unoccupied even when an agonist produces a maximal response. Such empty ones are called spare receptors. In presence of spare receptors the maximum effect of an agonist drug is achieved with fewer than 100% of the receptors being occupied. To determine the presence of spare receptors, scientists often compare the concentration of the drug needed to produce 50% of the maximum effect (EC50) with the concentration of the drug needed to occupy 50% of the receptors (Kd). If the...
Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...


